DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

Iqbal Iqbal, S Verheye, A Abizaid, J Ormiston, T Vries, L Morrison, S Toyloy, P Fitzgerald, S Windecker, PWJC (Patrick) Serruys

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)e1336-e1342
Issue number11
Publication statusPublished - 2016

Cite this